This category encompasses active pharmaceutical ingredients, such as migalastat and miglustat, alongside synthetic analogues and stable isotope labelled compounds. Researchers rely on these high-quality reference standards for precise impurity profiling, structural elucidation, and quantitative analysis in biological matrices. By providing reliable benchmarks for assessing enzymatic inhibition, these products facilitate the development of targeted therapies and support rigorous quality control processes within the biopharmaceutical sector.









